Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


In situ cultivation of previously uncultivable microorganisms using the ichip.

Berdy B, Spoering AL, Ling LL, Epstein SS.

Nat Protoc. 2017 Oct;12(10):2232-2242. doi: 10.1038/nprot.2017.074. Epub 2017 Sep 29.


Reducing the Bottleneck in Discovery of Novel Antibiotics.

Jones MB, Nierman WC, Shan Y, Frank BC, Spoering A, Ling L, Peoples A, Zullo A, Lewis K, Nelson KE.

Microb Ecol. 2017 Apr;73(3):658-667. doi: 10.1007/s00248-016-0889-3. Epub 2016 Nov 28.


A new antibiotic kills pathogens without detectable resistance.

Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schäberle TF, Hughes DE, Epstein S, Jones M, Lazarides L, Steadman VA, Cohen DR, Felix CR, Fetterman KA, Millett WP, Nitti AG, Zullo AM, Chen C, Lewis K.

Nature. 2015 Jan 22;517(7535):455-9. doi: 10.1038/nature14098. Epub 2015 Jan 7. Erratum in: Nature. 2015 Apr 16;520(7547):388.


Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2.

Gavrish E, Sit CS, Cao S, Kandror O, Spoering A, Peoples A, Ling L, Fetterman A, Hughes D, Bissell A, Torrey H, Akopian T, Mueller A, Epstein S, Goldberg A, Clardy J, Lewis K.

Chem Biol. 2014 Apr 24;21(4):509-518. doi: 10.1016/j.chembiol.2014.01.014. Epub 2014 Mar 27.


Isofuranonaphthoquinone produced by an Actinoplanes isolate.

Zhang Q, Peoples AJ, Rothfeder MT, Millett WP, Pescatore BC, Ling LL, Moore CM.

J Nat Prod. 2009 Jun;72(6):1213-5. doi: 10.1021/np8005716.


Neocitreamicins I and II, novel antibiotics with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci.

Peoples AJ, Zhang Q, Millett WP, Rothfeder MT, Pescatore BC, Madden AA, Ling LL, Moore CM.

J Antibiot (Tokyo). 2008 Jul;61(7):457-63. doi: 10.1038/ja.2008.62.

Supplemental Content

Loading ...
Support Center